ExeVir Bio | Valuation, Funding Rounds & Stock Price | Caplight

ExeVir Bio

Private
Belgium
Healthcare & Life Sciences ExeVir Website

Last Round: Grant
Date: Jun 28, 2023
Total Funding Raised: $108.78M

Company Overview

ExeVir Bio is a biotechnology company that develops single-domain antibody-based therapies for the treatment and prevention of infectious diseases.

Sector: Healthcare & Life Sciences
Verticals: Biotechnology, Drug Discovery, Clinical Trials
Business Model: B2B
Customer Profile: Services & Consulting
AI Layer: Non-AI
Keywords: nanobody, vhh, antibody, antibody therapy, camelid antibody, biotech, drug discovery, monoclonal antibody, viral infection treatment, clinical-stage biotech, multispecific antibody, cdmo partnership, drug pipeline, llama-derived antibody

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ExeVir Bio Comparables

Compare ExeVir Bio with similar companies based on industry and business-model similarity.

Company Similarity Market Cap
DiosCURE Therapeutics SE 89% Unlock
Cerberus Therapeutics 82% Unlock
Invivyd 79% Unlock
Comparable company 50% Unlock

ExeVir Bio Funding Rounds

Historical fundraising activity.

Round Date Amount Raised Valuation Investors Sources
Grant Jun 28, 2023 Unlock Unlock Unlock Unlock
Debt Dec 14, 2022 Unlock Unlock Unlock Unlock
Grant Jul 13, 2021 Unlock Unlock Unlock Unlock
Series A Mar 16, 2021 Unlock Unlock Unlock Unlock
Series A Jul 28, 2020 Unlock Unlock Unlock Unlock

Key People

Founding team and executive leadership

ExeVir Bio Investors

Notable investors and investment history.

Investor Rounds
UCB Ventures Series A
Federal Holding and Investment Company Series A
Sopartec Series A
Noshaq Series A
Fund+ Series A
Société Régionale d'Investissement de Wallonie Series A
UCB Ventures Series A

Market Signals

ExeVir Bio Filings

SEC and related filings with document metadata.

Typed Date Amount Offered Amount Sold Filling Pages Download
Mock Valuation Sign Up to view Mock Valuation Sign Up to view Mock Valuation Sign Up to view Mock Valuation
Mock Valuation Sign Up to view Mock Valuation Sign Up to view Mock Valuation Sign Up to view Mock Valuation
Mock Valuation Sign Up to view Mock Valuation Sign Up to view Mock Valuation Sign Up to view Mock Valuation
Mock Valuation Sign Up to view Mock Valuation Sign Up to view Mock Valuation Sign Up to view Mock Valuation

Frequently Asked Questions

Firmographic Details